欧洲罕见病患者的治疗途径:以阿塔克西亚为例
Julie Vallortigara1, Julie Greenfield2, Barry Hunt2
1Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square House, Queen Square, London, WC1N 3BG, UK.
Orphanet journal of rare diseases
|October 18, 2023
概括
与非专业机构相比,患有渐进性缩症的患者在专业缩症中心 (SAC) 对护理协调和管理的满意度更高. 这凸显了罕见神经系统疾病的专业护理的重要性.
科学领域:
- 神经学 神经学
- 患者护理途径 患者护理途径
- 罕见疾病 罕见疾病
背景情况:
- 渐进性是复杂的神经系统疾病,带来了诊断和管理的挑战.
- 了解在专业性中心 (SAC) 与非专业设置中的患者旅程至关重要.
- 专注于早期干预和不同国家的协调治疗.
研究的目的:
- 将SAC中的患者途径与非专业环境进行比较.
- 调查诊断,获得医疗保健,治疗和护理满意度.
- 分析早期干预和治疗协调,以抗氧症患者.
主要方法:
- 在英国,德国和意大利进行了一项患者调查.
- 在专业和非专业环境中收集关于诊断和管理的数据.
- 评估了初级/二级医疗保健服务的使用情况和患者满意度.
主要成果:
- 患者报告了SAC的积极经验,以了解他们的病情和管理.
- 专业医疗机构的价值被评估为量身定制的护理,协调的转诊和研究机会.
- 确定了在英国,德国和意大利访问SAC的类似障碍.
结论:
- 与非SAC相比,SAC中患者对护理的满意度一般更高.
- 这项研究提供了对欧洲阿塔克西亚患者护理途径的关键见解.
- 结果可以为改善罕见神经疾病治疗和护理的政策提供信息.
相关概念视频
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567


